 |
|
|
Sulazepam
|
|
| Systematic (IUPAC) name | |
| 7-chloro- 1-methyl- 5-phenyl- 1,3-dihydro- 2H- 1,4-benzodiazepine- 2-thione | |
| Identifiers | |
| CAS number | |
| ATC code | none |
| PubChem | |
| Chemical data | |
| Formula | C16H13ClN2S |
| Mol. mass | 300.81 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Sulazepam is a drug which is a benzodiazepine derivative. It is the thioamide derivative of diazepam. It is metabolised into diazepam, desmethyldiazepam and oxadiazepam. It has sedative, muscle relaxant, hypnotic, anticonvulsant and anxiolytic propertiess like those of other benzodiazepines.[1][2]
See also
References
- ^ "sulazepam". psychotropics.dk. 2003. http://www.psychotropics.dk/moleculeView/default.aspx?ID=1444&Catalogtype=A&ChapterID=1&Thissortorder=41. Retrieved 29 December 2008.
- ^ Golovenko NIa, Zin'kovskii VG (September 1976). "[Analysis of the structure of the components of the convulsive action of corazole following administration of sulazepam and its metabolites to mice]" (in Russian). Biull Eksp Biol Med 82 (9): 1078–81. PMID 11012.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
